Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.

Slides:



Advertisements
Similar presentations
Coagulopathies Hayley Morse May 29, 2008.
Advertisements

The Basics of Hemophilia
Basic coagulation techniques and Quality control issues
Chapter 12 Disorders of Hemostasis
Bleeding Disorders For Surgeons
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Bleeding Diathesis INTRODUCTION Shirazi MH 1/12/2009 K&CH.
Bleeding and coagulation disorders
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
Pathology of Coagulation I- Deficiency of Coagulation Factors II- II- HYPERCOAGULABLE STATES.
MLAB 1227: Coagulation Keri Brophy-Martinez
C51 Coagulation. “Bleeding” VS “Coagulation” Vessels –Bleeding Time Blood cells: –Platelet(c60.ppt ) Number, function Coagulation –S(+)LAB(+) –S(-)LAB(
Approach to the Bleeding Patient
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Inherited Coagulation Disorders Dr Galila Zaher Consultant Hematologist KAUH.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
The bleeding child diagnostic approach
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Blood disorders.
Hemostasis and Blood Coagulation
Bleeding Disorders Dr. Farjah H.AlGahtani
Approach to Bleeding Disorders
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
D ISODERS OF SECONDARY HEMOSTASIS Disorders of plasma clotting factors.
Mrs. M. Jansen van Vuuren Universitas Academic Hospital Bloemfontein.
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
BLEEDING DISORDERS LCDR ART GEORGE.
February 4 th, The Child With Pain Single Joint Involvement Multiple Joint Involvement With Fever Septic arthritis/Osteomyelitis Sympathetic arthritis.
Investigation of Haemostasis MS. c. program Lab-9.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Inherited bleeding disorder of primary hemostasis.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
PLATELETS (PLTs) or Thrombocytes Dr. Taj Platelets Thrombocytes are Fragments of megakaryocytes in bone marrow.
PRINCIPLES OF HEMATOLOGICAL DIAGNOSIS 1.HISTORY I-Medical history A.The present illness, focus on the following: 1.Bleeding. 2.Infection or symptoms related.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Approach to Petechiae And Purpura Supervised by:P.H.D.Khaled Khanji Presented by: Salah Eddin Younes Aleppo university hospital medical symposium.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Coagulation tests CBC- complete blood count
Clinical presentation of a child with abnormal bleeding Dr Barnabas R Atwiine.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Congenital bleeding disorders
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Approach To Bleeding Disorders In Neonates
Multiple choice questions
Chapter 18 Disorders of Hemostasis
Coagulation cascade:.
Biochemistry of Coagulation
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Hemostasis.
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Congenital bleeding disorders
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
The child with hematological dysfunction
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Approach to the Bleeding Child

Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations

Current History  an increase in severity or frequency of bleeding from one site e.g.; nose.  bleeding from unusual sites such as joints or internal organs.  excessive bleeding for the degree of the trauma experienced.

Bleeding History  Easy bleeding/bruising  into soft tissues/joints (think clotting factor deficiency, coagulation disorder)  epistaxis, menorrhagia, gum bleeding, mucous membranes (suggestive of platelet disorder, vascular)  GI bleeding, hematuria  previous surgeries, immunizations, tooth extractions, circumcision, etc  excessive bleeding with fractures, minor cuts  Significant or not? Generalized or localized?. Acquired or hereditary?  Time of presentation.

Bleeding history  Vascular and platelet dysfunction : Usually spontaneous subcutaneous or mucus membrane bleeding eg; purpura, petechiae, epistaxis  Coagulation factor deficiency: Bleeding usually occurs deep into joints, muscles, retroperitoneal space; post traumatic bleeds are often prolonged (sometimes hours).

Medical History  Age, Sex  Recent illness, medications?  Presence of chronic disease e.g.; renal or liver disease, malabsorption?  Nutritional status: decreased hepatic synthesis  Screen for other cytopenias systemic symptoms (wt loss, night sweats, fever, weakness) recurrent infections, sepsis anemia (fatigue, pallor)  Remember non-accidental trauma! Consider child abuse with unusual bruising

Family History  Detailed family history of bleeding disorders? sex linked recessive (hemophilia A,B,WAS) autosomal recessives disease : clotting factors defeciency 2,5,7,10,11,13. autosomal dominant : (VWF, qualitative platelet disorders, dysfibronogenimia) autoimmune disorders  Consanguinity  Race/descent e.g. factor XI in Ashkenazi Jews

Physical Examination Vital signs: Pulse, BP, RR, Temp General appearance, pallor Mucosal bleeding, joint/muscle hematomas Petechiae/purpura/ecchymosis, Splenomegaly +/- hepatomegaly Lymphadenopathy Signs of sepsis

Ecchymoses, Purpura, Petechiae

Physical examination Sites of hemorrhage – abdominal, pelvis, long bones, etc Evidence of chronic disease, malignancy. Delayed wound healing? Factor 13 deficiency, dysfibrinogenemia Musculoskeletal examination for bleeding and extensibility, dysmorphic features

Labs: Screening tests  Complete blood count  Peripheral blood film  PT/INR (extrinsic and common pathways)  Tissue factor, II, V, VII, X, fibrinogen  aPTT (intrinsic and common pathways) -II, V, VIII, IX, X, XI, XII, Fibrinogen  Bleeding time

TestMechanism testedRef value (Varies)Disorder PTExtrinsic & common pathways <12s beyond neonate, 12-18s in neonate Vit K related bleeding, HDN, malabsorption, Liver disease, oral anticoagulants aPTTIntrinsic & common pathways 20-40s beyond neonate, 70s in neonate Hemophilia, VWD, heparin, DIC, lupus anticoagulant, Factor XI & XII deficiency Thrombin Time Fibrinogen to fibrin10-15s beyond neonate, 12-17s in neonate Fibrin split products, DIC, heparin, uremia, hypofibrinogenemia Bleeding Time Hemostasis, capillary & platelet function 3-7minPlatelet dysfunction, thrombocytopenia, aspirin, von Willebrand disease Platelet count Platelet number150, ,000/ mm 3 Causes of Thrombocytopenia Thin FilmPlatelet number, size, RBC morphology Large platets-peripheral destruction, Fragmented RBCs- microangiopathic process

PT and aPTT Prolonged APTT Defect in Intrinsic No change in PT No change in APTT Defect in Extrinsic Prolonged PT Prolonged APTTDefect in common Prolonged PT

Additional labs  Specific factor assays  Mixing study (patient plasma 1:1 normal plasma)  Thrombin Time and Fibrinogen measurement  Urea clot lysis test (Factor XIII def)  Platelet function testing  VWF antigen and activity testing  Genetic testing